NSTEMI - NON-ST SEGMENT ELEVATION MI
Clinical trials for NSTEMI - NON-ST SEGMENT ELEVATION MI explained in plain language.
Never miss a new study
Get alerted when new NSTEMI - NON-ST SEGMENT ELEVATION MI trials appear
Sign up with your email to follow new studies for NSTEMI - NON-ST SEGMENT ELEVATION MI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cholesterol drug aims to cut heart attack deaths in half
Disease control OngoingThis study tests whether a drug called evolocumab, given after a heart attack, can lower bad cholesterol more effectively than standard treatments. About 2,166 adults who had a heart attack and needed a stent procedure will take part. The goal is to see if evolocumab helps preven…
Matched conditions: NSTEMI - NON-ST SEGMENT ELEVATION MI
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
Heart shock study tests escalating support to save lives
Disease control OngoingThis study looks at whether quickly increasing the use of mechanical heart pumps can help people survive a severe heart attack complicated by cardiogenic shock, where the heart can't pump enough blood. Researchers will follow 124 patients at 20 hospitals in the United States to s…
Matched conditions: NSTEMI - NON-ST SEGMENT ELEVATION MI
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
AI reads your Heart's electrical signals to spot blockages instantly
Diagnosis OngoingThis study uses artificial intelligence to analyze standard ECG readings from 800 people having a heart attack. The AI aims to quickly identify which artery is blocked and how severe the blockage is, helping doctors decide on the best treatment faster. Participants are adults wit…
Matched conditions: NSTEMI - NON-ST SEGMENT ELEVATION MI
Sponsor: Powerful Medical • Aim: Diagnosis
Last updated May 22, 2026 13:52 UTC
-
64,000-Patient trial tests 1-Hour heart attack diagnosis
Diagnosis OngoingThis study compares two blood test methods for diagnosing heart attacks in people with chest pain. The current standard measures a heart damage marker at arrival and again 3 hours later. The newer method does the same but only 1 hour apart, potentially speeding up emergency care.…
Matched conditions: NSTEMI - NON-ST SEGMENT ELEVATION MI
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated May 11, 2026 20:51 UTC